COSCIENS Biopharma Inc. (CSCI) — Working Capital to Net Assets Ratio

Latest as of June 2025: 154.6%

COSCIENS Biopharma Inc. (CSCI) has a Working Capital to Net Assets ratio of 154.6% as of June 2025. Working capital of $10.97 Million (current assets of $16.50 Million minus current liabilities of $5.53 Million) is measured against net assets of $7.10 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. For the complete balance sheet picture, see total assets of COSCIENS Biopharma Inc..

WC/NA Ratio

154.6%
Working Capital / Net Assets

Working Capital

$10.97 Million
USD

Current Assets

$16.50 Million
USD

Current Liabilities

$5.53 Million
USD

COSCIENS Biopharma Inc. Working Capital to Net Assets (1996–2024)

This chart shows how COSCIENS Biopharma Inc.'s Working Capital to Net Assets ratio has evolved across 29 annual periods from 1996 to 2024. As of June 2025, the ratio stands at 154.6%, reflecting working capital of $10.97 Million against net assets of $7.10 Million USD. Explore CSCI capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

Annual Working Capital to Net Assets for COSCIENS Biopharma Inc. (1996–2024)

The table below presents the year-by-year Working Capital to Net Assets ratio for COSCIENS Biopharma Inc. from 1996 to 2024, covering 29 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read debt load of COSCIENS Biopharma Inc. for a breakdown of total debt and financial obligations.

Year WC/NA Ratio Working Capital (USD) Net Assets Current Assets Current Liabilities Change (pp)
2024 127.3% $16.76 Million $13.16 Million $23.98 Million $7.22 Million ▲ +80.0 pp
2023 47.3% $9.96 Million $21.04 Million $11.27 Million $1.31 Million ▲ +13.2 pp
2022 34.2% $8.13 Million $23.79 Million $15.17 Million $7.04 Million ▲ +25.1 pp
2021 9.1% $1.98 Million $21.74 Million $9.73 Million $7.76 Million ▼ -3.3 pp
2020 12.4% $2.36 Million $19.06 Million $7.10 Million $4.74 Million ▼ -8.6 pp
2019 20.9% $3.58 Million $17.08 Million $4.91 Million $1.33 Million ▲ +0.4 pp
2018 20.6% $3.51 Million $17.04 Million $4.50 Million $998.35K ▼ -1.3 pp
2017 21.9% $3.92 Million $17.93 Million $7.15 Million $3.23 Million ▼ -17.7 pp
2016 39.6% $6.59 Million $16.67 Million $8.48 Million $1.89 Million ▲ +103.9 pp
2015 -64.4% $-3.65 Million $5.68 Million $2.77 Million $6.42 Million ▼ -1.4 pp
2014 -62.9% $-1.13 Million $1.80 Million $1.42 Million $2.55 Million ▼ -446.0 pp
2013 383.0% $879.52K $229.62K $2.96 Million $2.08 Million ▲ +1772.6 pp
2012 -1389.6% $-189.45K $13.63K $2.39 Million $2.58 Million ▼ -1458.0 pp
2011 68.5% $347.14K $507.11K $1.83 Million $1.48 Million ▼ -57.2 pp
2010 125.7% $-823.16K $-654.90K $1.11 Million $1.93 Million ▲ +33.0 pp
2009 92.7% $-1.22 Million $-1.31 Million $807.73K $2.02 Million ▼ -31.1 pp
2008 123.8% $-1.96 Million $-1.59 Million $869.07K $2.83 Million ▲ +32.1 pp
2007 91.7% $1.44 Million $1.57 Million $2.30 Million $860.59K ▼ -119.1 pp
2006 210.8% $549.41K $260.64K $1.10 Million $552.50K ▼ -40834.5 pp
2005 41045.3% $163.04 Million $397.23K $163.68 Million $633.85K ▲ +41161.4 pp
2004 -116.1% $-110.15K $94.89K $776.38K $886.53K ▼ -158.8 pp
2003 42.7% $125.99K $294.75K $700.30K $574.30K ▲ +4.4 pp
2002 38.4% $-159.12K $-414.76K $236.19K $395.31K ▲ +7.5 pp
2001 30.9% $-220.73K $-714.40K $171.23K $391.96K ▼ -54.1 pp
2000 84.9% $-1.35 Million $-1.59 Million $120.42K $1.47 Million ▼ -15.1 pp
1999 100.0% $-1.31 Million $-1.31 Million $138.09K $1.45 Million ▼ -18.2 pp
1998 118.2% $-844.87K $-714.89K $129.98K $974.85K ▲ +151.2 pp
1997 -33.0% $-2.17 Million $6.57 Million $209.64K $2.38 Million ▼ -5.5 pp
1996 -27.5% $-1.61 Million $5.84 Million $2.41 Million $4.01 Million
pp = percentage points